The weekly litigation news digest is live. Subscribe now

Wittkopp patent opposition analysis

The comprehensive analysis of Wittkopp opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Wittkopp

Patent NumberTitleApplicantOpposition DateOpposition Company
Fenfluramine Compositions And Methods Of Preparing The SameZOGENIXOct 29, 2025ALFRED E TIEFENBACHER
Nalmefene For Reduction Of Alcohol Consumption In Specific Target PopulationsH LUNDBECKOct 27, 2025ALFRED E TIEFENBACHER
Methods For Treating Hypertrophic CardiomyopathyCYTOKINETICSOct 14, 2025HAMM & WITTKOPP
Biomarkers For A Therapy Comprising A Sorafenib CompoundEISAI R&D MANAGEMENTOct 8, 2025STADA ARZNEIMITTEL
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 16, 2025HAMM & WITTKOPP
Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCESSep 2, 2025HAMM & WITTKOPP
Pharmaceutical FormulationsGILEAD SCIENCESSep 2, 2025HAMM & WITTKOPP
Processes For Preparing Jak Inhibitors And Related Intermediate CompoundsINCYTEAug 12, 2025HAMM & WITTKOPP
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 23, 2025HAMM & WITTKOPP
Cannabidiol Preparations And Its UsesGW RESEARCHJul 22, 2025HAMM & WITTKOPP